Vitamin B6 (Pyridoxine / Pyridoxal-5'-Phosphate) for Premenstrual Syndrome

Verdict: Modest, reproducible benefit for PMS symptoms

Vitamin B6 (50–100 mg/day) appears to modestly ease overall premenstrual symptoms and premenstrual low mood, but the supporting trials are mostly small and methodologically dated, so this rates as preliminary rather than firmly established. It is best viewed as a low-risk adjunct, not a replacement for first-line PMS treatment.

B 🟡 B Preliminary Evidence Published

🔬Why this grade7-layer evidence engine

The grade reflects a consistent but limited evidence base. The landmark Wyatt meta-analysis of nine trials (PMID 10334745, n=940) found B6 more than twice as likely as placebo to relieve overall PMS symptoms (OR 2.32, 95% CI 1.95-2.54) and depressive symptoms (OR 1.69, 95% CI 1.39-2.06), favoring doses up to 100 mg/day. Smaller later randomized trials reproduced this signal: a triple-blind RCT at 40 mg/day (PMID 21241460, n=90, P<0.05) and a double-blind RCT at 80 mg/day (PMID 26989667, n=94, P<0.001). A magnesium-plus-B6 trial (PMID 33210604, n=264) also hinted at added mood benefit.

It stays at preliminary rather than strong evidence because the trials are small, use inconsistent PMS scales, and rely on older blinding methods; the authors themselves graded the body of evidence as only moderate quality. Professional bodies treat B6 as a 'may consider' option, not a first-line therapy. The Cleveland Clinic notes only that 'vitamins such as B-6 and magnesium may also reduce your symptoms,' without endorsing a specific dose.

Safety is the key caveat. The doses studied for PMS (40-100 mg/day) exceed several regulators' supplement limits: UK NHS advises no more than 10 mg/day from supplements without medical advice, EFSA sets a tolerable upper limit of 12.5 mg/day, and chronic intake at or above 200 mg/day can cause peripheral nerve damage. Australia will restrict doses above 50 mg/day to pharmacist supply from 2027. Effective doses therefore warrant caution and ideally clinician guidance.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.69
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
B · Published
Confidence
81%
Highly consistent evidence
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L1 ExamineGlobal benchmark
0.50
L5 Clinical bodiesAuthoritative stance
0.63
L3 MechanismPlausibility
0.65
L11 AI re-checkIndependent read
0.65
L2 PubMedPrimary literature
0.85
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.691
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review
PMID: 10334745 1999 統合分析 n = 940
Finding: Landmark Wyatt et al. systematic review and meta-analysis (BMJ 1999) of 9 published trials (n=940). Vitamin B6 was more than twice as likely as placebo to provide overall PMS symptom relief (OR 2.32, 95% CI 1.95 to 2.54) and depressive symptom relief (OR 1.69, 95% CI 1.39 to 2.06). Authors concluded doses up to 100 mg/day are likely beneficial; methodological quality of included trials was limited but signal was robust.
Academic Effect size: [object Object]
View on PubMed
Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review
PMID: 10334745 1999 統合分析 n = 940
Finding: Landmark Wyatt et al. systematic review and meta-analysis (BMJ 1999) of 9 published trials (n=940). Vitamin B6 was more than twice as likely as placebo to provide overall PMS symptom relief (OR 2.32, 95% CI 1.95 to 2.54) and depressive symptom relief (OR 1.69, 95% CI 1.39 to 2.06). Authors concluded doses up to 100 mg/day are likely beneficial; methodological quality of included trials was limited but signal was robust.
Academic Effect size: [object Object]
View on PubMed
The effect of vitamin B6 on premenstrual syndrome symptoms: a randomized clinical trial
PMID: 26989667 2016 隨機對照試驗 n = 94
Finding: Iranian double-blind RCT in college students with PMS. Vitamin B6 80 mg/day significantly reduced overall PMS symptom score, including emotional and physical subscales, compared with placebo after 2 cycles (P<0.001). Replicates direction and magnitude of effect seen in Wyatt 1999 meta-analysis.
Academic
View on PubMed
Impact of magnesium supplementation, in combination with vitamin B6, on stress and magnesium status: secondary data from a randomized controlled trial
PMID: 33210604 2020 隨機對照試驗 n = 264
Finding: Pre-specified secondary analysis showed adding 30 mg/day B6 to magnesium produced a greater stress-score reduction in severely stressed adults with low magnesemia (between-group difference 3.16 points, 95% CI 0.50-5.82, p=0.0203). Not a dedicated PMS endpoint, but supports B6 contribution to affective symptoms relevant to PMS dimensions.
⚠️ Industry-funded Effect size: [object Object]
View on PubMed
Effects of vitamin B6 on premenstrual syndrome: a triple-blind randomized clinical trial
PMID: 21241460 2011 隨機對照試驗 n = 90
Finding: Triple-blind RCT in young women showing 40 mg/day vitamin B6 significantly improved PMS symptom severity vs placebo over 3 cycles (P<0.05). Adverse events comparable to placebo at this dose; consistent with safety profile of doses <=100 mg/day.
Academic
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
PYRIDOXINE — CAS 65-23-6 — SCOGS no. 100 — 21 CFR 101.9, 170.3(o) — Generally Recognized as Safe (referenced via SCOGS); permitted use: NUTRIENT SUPPLEMENT. source↗
L4b EU EFSA
Supportive
the Panel established a tolerable upper intake level (UL) for vitamin B6 of 12.5 mg/day for adults, including pregnant and lactating women source↗
L4c UK NHS
Cautious
Taking 200mg or more a day of vitamin B6 can lead to a loss of feeling in the arms and legs known as peripheral neuropathy. ... Do not take more than 10mg of vitamin B6 a day in supplements unless advised to by a doctor. source↗
L4d TW TFDA / 衛福部
Supportive
維生素B6成人每日建議攝取量為1.5毫克,上限攝取量為80毫克 source↗
L4e WHO
Cautious
From 1 June 2027, oral preparations containing 50 mg or less per recommended daily dose will continue to be available for general retail sale. Oral preparations containing more than 50 mg but not more than 200 mg per recommended daily dose will be available over the counter with the advice of a pharmacist. Oral preparations containing more than 200 mg per recommended daily dose will continue to… source↗
L5a NIH Office of Dietary Supplements
Supportive
The American College of Obstetrics and Gynecology (ACOG) recommends monotherapy with 10–25 mg of vitamin B6 three or four times a day to treat nausea and vomiting in pregnancy. source↗
L5c Cleveland Clinic
Supportive
Vitamins such as B-6 and magnesium may also reduce your symptoms. source↗
L5d Harvard Health
Supportive
L5e Specialty Society (condition-mapped)
Cautious
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-pms-INT-vitamin-b6-001 繁體中文版 →